A major limitation with current tissue-engineering approaches is creating functionally vascularized constructs that can successfully integrate with the host; this often leads to implant failure, due to avascular necrosis. In order to overcome this, the objective of the present work was to develop a method to incorporate growth factor-eluting alginate microparticles (MPs) into freeze-dried, collagen-based scaffolds. A collagen-hydroxyapatite (CHA) scaffold, previously optimized for bone regeneration, was functionalized for the sustained delivery of an angiogenic growth factor, vascular endothelial growth factor (VEGF), with the aim of facilitating angiogenesis and enhancing bone regeneration. VEGF was initially encapsulated in alginate MPs b...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
A major limitation with current tissue-engineering approaches is creating functionally vascularized ...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The spatiotemporally controlled delivery of the pro-osteogenic factor rhBMP-2 would overcome most of...
The spatiotemporally controlled delivery of the pro-osteogenic factor rhBMP-2 would overcome most of...
One of the major challenges of bone tissue engineering applications is to construct a fully vascular...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
A major limitation with current tissue-engineering approaches is creating functionally vascularized ...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The success of any tissue engineering implant relies upon prompt vascularization of the cellular con...
The spatiotemporally controlled delivery of the pro-osteogenic factor rhBMP-2 would overcome most of...
The spatiotemporally controlled delivery of the pro-osteogenic factor rhBMP-2 would overcome most of...
One of the major challenges of bone tissue engineering applications is to construct a fully vascular...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...
International audienceIn bone tissue engineering, autologous cells are combined with osteoconductive...